Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy-Reference-Cited by-同舟云学术

Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy

Published:2020-01-01 Issue:1 Volume:42 Page:966-968
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Suzuki Tomo¹²,Han Wei¹,Watanabe Shiika¹,Terashita Maho¹,Nakata Mayumi¹,Ichikawa Daisuke¹,Shirai Sayuri³,Shibagaki Yugo¹

Affiliation:

1. Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

2. Department of Nephrology, Kameda Medical Center, Chiba, Japan

3. Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2020.1819318

Reference9 articles.

1. Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy

2. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy

3. A Mechanism for Cancer-Associated Membranous Nephropathy

4. Expression of THSD7A in neoplasm tissues and its relationship with proteinuria

5. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histological transition from minimal change disease to THSD7A-associated membranous nephropathy in a patient receiving long-term steroid treatment: A case report;Medicine;2023-10-13

2. Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience;World Journal of Clinical Cases;2023-01-26

3. Spontaneous Remission of Thrombospondin Type-1 Domain-Containing-Associated Membranous Nephropathy;Internal Medicine;2021-10-01